Cita APA

Pérez Ruiz, M., Bos, M. t., Fernández García, P., Manuel, C. d., Morales Tirado, A., López Neyra, A., . . . Sanz Santiago, V. (2025). Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Aerobic Capacity in Children With Cystic Fibrosis Aged 6–11 Years: Actual Observations and Clinical Perspectives.

Citación estilo Chicago

Pérez Ruiz, Margarita, Mats te Bos, Patricia Fernández García, Cristina de Manuel, Ana Morales Tirado, Alejandro López Neyra, Marta Ruiz de Valbuena, Margarita Rubio Alonso, y Verónica Sanz Santiago. Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor On Aerobic Capacity in Children With Cystic Fibrosis Aged 6–11 Years: Actual Observations and Clinical Perspectives. 2025.

Cita MLA

Pérez Ruiz, Margarita, et al. Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor On Aerobic Capacity in Children With Cystic Fibrosis Aged 6–11 Years: Actual Observations and Clinical Perspectives. 2025.